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ABSTRACT
OBJECTIVE:  A cross-sectional population-based study was conducted to 
assess, in active smokers, the relationship of number of cigarettes smoked and 
other characteristics to salivary cotinine concentrations.
METHODS: A random sample of active smokers aged 15 years or older was 
selected using a stepwise cluster sample strategy, in the year 2000 in Rio de 
Janeiro, Brazil. The study included 401 subjects. Salivary cotinine concentration 
was determined using gas chromatography with nitrogen-phosphorus detection. 
A standard questionnaire was used to collect demographic and smoking 
behavioral data. The relation between the number of cigarettes smoked in the 
last 24h and cotinine level was examined by means of a nonparametric fi tting 
technique of robust locally weighted regression.
RESULTS: Signifi cantly (p<0.05) higher adjusted mean cotinine levels 
were found in subjects smoking their fi rst cigarette within fi ve minutes after 
waking up, and in those smoking 1–20 cigarettes in the last 24h who reported 
inhaling more than ½ the time. In those smoking 1–20 cigarettes, the slope 
was signifi cantly higher for those subjects waiting for more than fi ve minutes 
before smoking their fi rst cigarette after waking up, and those smoking “light” 
cigarettes when compared with their counterparts. These heterogeneities became 
negligible and non-signifi cant when subjects with cotinine >40 ng/mL per 
cigarette were excluded.
CONCLUSIONS: There was found a positive association between self-
reporting smoking fi ve minutes after waking up, and inhaling more than ½ 
the time are consistent and higher cotinine levels. These can be markers of 
dependence and higher nicotine intake. Salivary cotinine proved to be a useful 
biomarker of recent smoking and can be used in epidemiological studies and 
smoking cessation programs.
KEY WORDS: Smoking. Cotinine, pharmacokinetics. Cross-sectional 
studies.   
miolo41_6.indb   954 14/11/2007   18:12:12
955Rev Saúde Pública 2007;41(6):954-62
Nicotine has a short half-life and its major metabolite is 
cotinine. Cotinine has a half-life of 16–20 hours and is a 
useful indicator of nicotine intake from recent smoking. 
About 70% to 80% of nicotine absorbed into the blood 
stream is converted into cotinine.5 Thus, measurement 
of cotinine in biological samples provides is an objec-
tive approach to identify recent smoking exposure.5
In smokers, the level of cotinine is determined by many 
factors which vary widely for the same number of ciga-
rettes smoked per day. Factors potentially infl uencing 
cotinine levels relate to the product smoked (fi lter or 
non-fi lter and nicotine yield), the way the product 
is smoked (depth of inhalation and butt length), and 
smoker characteristics (age, gender, and phenotype 
of nicotine metabolism).15 Cotinine levels also vary 
across racial groups, perhaps refl ecting differences in 
some of these factors.3,10 These racial differences are of 
interest and may refl ect intrinsic metabolic differences, 
differences related to the circumstances of exposure, 
such as frequency and depth of smoking,3,22 or diffe-
rential accuracy in self-reported number of cigarettes 
smoked recently.1 The heterogeneity of effects by ethnic 
background also suggests that other variables may 
modify the observed relationship between number of 
cigarettes smoked and cotinine concentration. If this is 
the case, these variables would have to be taken into 
consideration when assessing the value of cotinine as 
a marker of recent smoking exposure.
Although the relationship between salivary cotinine 
and number of cigarettes smoked has been studied for 
specifi c ethnic groups, the replication of prior fi ndings 
in a previously unstudied country with different genetic 
and cultural characteristics is novel and important. The 
present study is part of a multi-country study, which 
also included China, Mexico and Poland, aiming at 
the assessment of the association between cigarette 
characteristics and smoking behavior and salivary co-
tinine. The objective of the present study was to assess 
INTRODUCTION
RESUMO
OBJETIVO: Realizou-se um estudo transversal para analisar a relação entre 
número de cigarros fumados e outras características com a concentração de 
cotinina salivar entre fumantes.
MÉTODOS: Fumantes ativos de 15 anos ou mais foram selecionados por 
meio de amostra probabilística em múltiplos estágios no ano 2000, município 
do Rio de Janeiro, Brasil. O estudo incluiu 401 fumantes. A concentração 
de cotinina salivar foi determinada utilizando-se cromatografi a gasosa com 
detector de nitrogênio/fósforo. Coletaram-se informações demográfi cas e sobre 
o comportamento tabágico utilizando-se questionário padronizado. A relação 
entre o número de cigarros fumados nas últimas 24h e o nível de cotinina foi 
analisada utilizando técnica não paramétrica baseada em regressões robustas 
locais ponderadas.
RESULTADOS: O nível médio ajustado de cotinina foi signifi cativamente 
(p<0,05) mais elevado entre indivíduos que fumaram o primeiro cigarro até 
cinco minutos depois de acordar e entre os que fumaram de um a 20 cigarros nas 
últimas 24h e tragavam mais de metade das vezes. Considerando-se fumantes 
de um a 20 cigarros, a inclinação da curva de regressão foi signifi cativamente 
maior entre os que, após acordar, esperam mais de cinco minutos para fumar e 
para os que consumiam cigarros “suaves”, quando comparados a seus opostos. 
Essas heterogeneidades desaparecem ao se excluir indivíduos com cotinina 
inferior a 40 ng/ml/cigarro.
CONCLUSÕES: Houve associação positiva entre referir fumar até cinco 
minutos depois de acordar e tragar mais da metade das vezes e níveis de cotinina 
salivar. Essas informações podem ser marcadores de dependência e maior 
absorção de nicotina entre fumantes. A cotinina salivar mostrou-se útil como 
biomarcador do uso recente de tabaco a ser usado em estudos epidemiológicos 
e programas de cessação de fumar.
DESCRITORES: Tabagismo. Cotinina, farmacocinética. Estudos 
transversais.
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in active smokers the relationship between number of 
cigarettes and other characteristics and salivary cotinine 
concentrations in an admixed population, and to exa-
mine whether certain variables modify the relationship 
of number of cigarettes to cotinine.
METHODS
In 2000, a cross-sectional survey was conducted based 
on a random sample of the metropolitan population 
of the city of Rio de Janeiro, Brazil. A stepwise clus-
ter strategy was used. Eligible household members 
consisted of individuals aged 15 years or older living 
in Rio. Only active cigarette smokers were included. 
Individuals using nicotine replacement therapy, those 
with cotinine concentration under 10 ng/mL, and those 
from whom saliva samples could not be obtained were 
excluded. In addition, individuals who did not smoke 
at least one cigarette per day during the month prior 
to the interview and those who did not smoke in the 
previous 24 hours were excluded.
The total random sample included 2,393 subjects, 
representing a response rate of 96.5%. Subjects were 
interviewed in the households by trained interviewers 
after obtaining their informed consent. Information 
was collected on age, gender, education, smoking his-
tory and smoking behavior variables using a standard 
questionnaire. The latter included average number of 
cigarettes smoked daily, number of cigarettes smoked in 
the previous 24 hours, duration of smoking, depth and 
frequency of inhalation and type of cigarette. The Fa-
gerström Test for Nicotine Dependence index (FTND)12 
and whether their fi rst cigarette was smoked within fi ve 
minutes after waking up were both used as dependence 
indicators. Weight was measured in kilograms using a 
portable scale. Height was measured without shoes in 
meters using a tape mounted on the wall. Body mass 
index (BMI) was calculated as weight divided by the 
square of the height. Stringent quality assurance and 
control procedures were followed.
Saliva samples were collected from smokers in the 
households shortly after the interviews. Subjects were 
asked to spit approximately six milliliters of saliva in 
a test tube. Specimens were frozen, stored at –20oC, 
and shipped for cotinine measurements to the Clinical 
Pharmacology Laboratory at San Francisco General 
Hospital, University of California, San Francisco. Coti-
nine concentration was determined using gas chromato-
graphy with nitrogen-phosphorus detection.18 Cotinine 
concentrations were determined using standard curves 
ranging from 10 to 5,000 ng/mL. The lower limit of the 
test’s sensitivity was 10 ng/mL.
Regarding data analysis, fi rst frequency distributions 
were assessed. The shape of the function expressing the 
relationship between number of cigarettes smoked in 
the last 24 hours and cotinine levels was examined by 
means of a nonparametric fi tting technique of robust 
locally weighted regression (LOWESS).
Crude and adjusted means of salivary cotinine con-
centration were calculated for categories of selected 
variables, separately for those smoking 1–20 and those 
smoking 21–40 cigarettes in the last 24 hours. Linear 
regression was used for multiple adjustment using mean 
cotinine ng/mL as the outcome. Covariates included 
demographic and socioeconomic variables (age, gen-
der, educational level), BMI, and smoking behavior 
variables. Variables for which effect modification 
was suspected upon stratifi cation were included in the 
regression models as interaction terms. For the multi-
variable models it was used as a marker of dependence 
the amount of time subjects wait to smoke their fi rst 
cigarette after waking up.
Cotinine concentrations greater than 40 ng/mL per 
cigarette smoked in the previous 24 hours (cot>40) are 
believed to be unlikely from a biological viewpoint, 
possibly resulting from information or measurement 
bias. The rationale for excluding values >40 ng/mL per 
cigarette is based on studies of how much nicotine a 
person can take in from a cigarette and nicotine and co-
tinine metabolism rate. Commercial cigarettes typically 
contain 10–15 mg nicotine per tobacco rod. The usual 
systemic absorption of nicotine from a cigarette is 1–1.5 
mg but can be as high as three milligrams per cigarette 
with very intense smoking.6 In experimental studies 
in which cigarette smoking is measured and in which 
nicotine and cotinine pharmacokinetic parameters are 
characterized, the typical cotinine concentration per 
cigarette is 12 ng/mL.5 Assuming this refl ects an intake 
of one milligram of nicotine, one can estimate a cotinine 
level of 36 ng/mL for a person taking in 3 mg nicotine 
from each cigarette. To be conservative it was set a 
limit of 40 ng/mL per cigarette as a limit above which 
a level would be considered biologically implausible. 
Thus, in supplementary sensitivity analyses, subjects 
with such values were excluded.
Analyses were performed using Stata Statistical Soft-
ware package, release 8.0.
The study was approved by the institutional review 
boards of Instituto Nacional do Câncer (Brazilian Na-
tional Cancer Institute), and Johns Hopkins Bloomberg 
School of Public Health. Subjects’ informed consents 
were obtained.
RESULTS
Of a total of 2,393 subjects, 513 (21.4%) were current 
active smokers. Overlapping reasons for exclusion 
were use of nicotine replacement therapy (13 subjects), 
smoking cigars or pipes (17), cotinine concentration 
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Table 1. Characteristics of all interviewees and current active smokers. Rio de Janeiro, Southeastern Brazil, 2001.
Variable All interviewees* (N=2,393) Active smokers** (N=401)***
Individual characteristic N % N %
Age (in years)
15–34 995 41.7 111 27.7
35–54 892 37.4 218 54.4
55–89 498 20.9 72 17.9
Gender
Males 1,032 43.1 194 48.4
Education
Up to high school 1,246 52.3 244 61.1
BMI****
< 24 1,154 48.2 201 50.1
Smoking prevalence
Current 513 21.4 401 100.0
Former 416 17.4 - -
Cigarettes smoked daily on average*****
1–10 - - 190 47.4
11–20 - - 161 40.1
21–30 - - 28 7.0
31 - - 22 5.5
Cigarettes smoked in the previous 24 hours*****
1–10 - - 143 35.8
11–20 - - 189 47.3
21–30 - - 33 8.3
31 - - 35 8.8
When do you have your fi rst cigarette after waking up*****
Within 5 minutes - - 142 35.4
6–30 minutes - - 124 30.9
31–60 minutes - - 39 9.7
1 hour - - 96 27.0
Frequency of inhaling*****
< 1/2 the time - - 51 12.7
1/2 the time - - 23 5.7
> 1/2 the time - - 15 3.7
Always - - 312 77.8
Depth of inhaling*****
Never - - 26 6.0
Lightly - - 164 40.9
Moderately - - 139 34.7
Deeply - - 74 18.4
Duration (years)*****
< 25 - - 202 50.4
> 25 - - 199 49.6
Fagerstrom Index*****
Very low - - 123 30.7
Low - - 93 23.2
Medium - - 58 14.5
High - - 90 22.4
Very high - - 37 9.2
Type of cigarette*****
Light - - 282 70.3
Regular - - 119 29.7
* The following information was missing (number of subjects): education (11) and age (1)
** 112 current active smokers were excluded for various reasons (see text)
*** Information was missing for 2 subjects on education, and for 1 subject on number of cigarettes smoked in the previous 
24 hours
**** BMI = body mass index (weight/height2 in kg/m2)
***** Current smokers
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under 10 ng/mL (42), failure to collect saliva (9), not 
having smoked at least one cigarette per day in the 
last month or in the 24 hours preceding the interview 
(87), and discrepant values between average number of 
cigarettes and number of cigarettes smoked in the last 
24 hours (one subject). After these exclusions, there 
remained 401 current active smokers. For sensitivity 
analyses, an additional 35 subjects who reported smok-
ing 1–20 cigarettes in the past 24 hours were excluded 
because of cotinine values greater than 40 ng/dL per 
cigarette smoked. These unlikely values were not seen 
in those smoking more than 20 cigarettes.
Table 2. Crude and adjusted* mean cotinine concentration in subjects who reported smoking 20 cigarettes or less and 21 to 
40 cigarettes. Rio de Janeiro, Southeastern Brazil, 2001.
Individual characteristic Cigarettes smoked in the last 24 hours
1–20 21–40 
Salivary cotinine level 
per cigarette >0
0 < Salivary cotinine level
 per cigarette > 40
Salivary cotinine level




















15–34 184.3 (125.4) 196.6 172.9 (123.2) 176.6 194.7 (134.1) 183.7
35–54 215.9 (141.1) 214.3 203.2 (134.3) 204.5 293.4 (133.4) 293.9
55–89 226.1 (150.9) 208.8 221.1 (143.3) 210.7 295.0 (121.6) 302.7
Gender 
Female 199.6 (129.0) 202.6 186.9 (124.7) 192.3 266.8 (145.5) 264.2
Male 217.7 (148.9) 214.1 208.7 (142.1) 202.7 284.8 (125.9) 286.9
Schooling*****
Complete high 
school or more 
197.3 (136.2) 197.0 194.9 (135.1) 194.5 250.9 (114.4) 298.0
Up to high school 216.1 (140.4) 215.1 199.9 (132.5) 199.2 329.7 (157.9) 232.9
BMI******
> 24 193.9 (132.6) 194.1 182.5 (124.1) 181.6 255.9 (143.2) 248.2
< 24 221.9 (143.7) 221.7 211.9 (140.9) 212.9 302.3 (119.9) 311.8
When do you have your fi rst cigarette after waking up 
> 6 minutes 181.5 (124.3) 190.7 171.4 (118.1) 186.0 219.2 (116.6) 230.4
“within 5 minutes” 273.2 (151.2) 250.4 261.5 (147.5) 225.1 311.9 (133.3) 304.9
Duration (years)  
< 25 182.6 (126.8) 193.1 171.5 (122.0) 191.6 259.7 (135.9) 294.1
> 25 236.3 (146.3) 221.3 226.3 (139.9) 203.5 290.5 (133.2) 262.1
Depth of inhaling 
Never/ lightly 199.6 (130.8) 213.5 183.7 (121.1) 200.9 297.8 (148.9) 268.9
Moderately/ deeply 216.5 (146.2) 202.5 210.0 (143.2) 193.7 265.7 (126.4) 291.5
Frequency of inhaling
< 1/2 the time 177.8 (144.2) 174.3 168.5 (137.3) 173.6 367.8 (164.9) 344.6
> 1/2 the time 215.4 (136.7) 216.2 204.4 (131.6) 203.2 262.2 (124.4) 265.8
Type of cigarette 
Light 203.3 (137.5) 207.5 195.6 (135.6) 201.8 253.7 (125.4) 262.8
Regular 221.2 (142.2) 209.5 201.8 (127.0) 183.4 303.2 (141.2) 292.6
Bold values: difference signifi cant at α=0.05
* Multiple linear regression was used in the analyses
** 181 current active smokers were excluded for various reasons (see text)
*** 216 current active smokers were excluded for various reasons (see text)
**** Each variable adjusted simultaneously for all other variables shown in the table and number of cigarettes smoked in the 
past 24 hours 
***** Information was missing for 2 subjects on education for those who smoked 1–20 cigarettes in the past 24 hours
****** BMI: body mass index (=weight/height2 in kg/m2)
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For the total population sample, 39% reported current or 
past smoking. Compared with the total random sample, 
current smokers were more likely to be older, male and 
less educated (Table 1). Among current smokers, the 
proportions smoking a daily average of 20 or fewer 
cigarettes, or smoking this same amount in the 24 
hours prior to saliva collection were 87.5% and 83.1%, 
respectively. Approximately 1/3 reported smoking their 
fi rst cigarette within 5 minutes after waking up. About 
78% reported always inhaling but only around 18% 
were deep inhalers. Half of current smokers reported 
smoking for 25 years or longer. About 1/3 had high or 
very high FTND index scores, and close to 70% smoked 
“light” cigarettes.
Two approximately straight lines with an infl ection 
point at about 20 cigarettes characterized the relation-
ship between number of cigarettes smoked in the prior 
24 hours and salivary cotinine concentration (Figure). 
The predicted slope was much steeper for subjects who 
reported smoking 1–20 cigarettes (8.0 ng/mL) than for 
those reporting more than 20 cigarettes (1 ng/mL).
Table 2 shows mean salivary cotinine concentrations 
according to selected variables, for two categories of 
number of cigarettes (1–20 and 21–40), and both before 
and after excluding those smoking 1–20 cigarettes with 
cotinine levels greater than 40 ng/mL (cot>40). The 
adjusted values refl ect simultaneous adjustment for the 
number of cigarettes as well as for all other variables 
shown in Table 2.
Although not statistically signifi cant at α=0.05, higher 
cotinine levels were consistently found for older com-
pared to younger subjects and for men, compared to 
women. No consistent or signifi cant differences were 
found for educational level.
Subjects with lower BMI (<24) had higher cotinine 
concentrations than those with higher BMI, and the 
adjusted difference was found to be signifi cant (p<0.05) 
after excluding smokers of 1–20 cigarettes with cot>40. 
Those who reported smoking their fi rst cigarette within 
fi ve minutes after waking up had higher levels of sa-
livary cotinine than those who waited longer than fi ve 
minutes before starting to smoke, and these differences 
were signifi cant for the adjusted values both before and 
after excluding persons with cot>40, and regardless 
of the category of number of cigarettes smoked (1–20 
or >20).
Duration of smoking and depth of inhaling were not 
signifi cantly related to cotinine concentrations, but 
those subjects in the 1–20 cigarettes category who 
reported inhaling more frequently (>1/2 time) had a 
higher cotinine concentration than their counterparts, 
and the adjusted difference was found to be signifi cant 
before excluding those with cot>40. No consistent or 
signifi cant differences were seen with regard to type of 
cigarette (light vs. regular).
Because the slope for those smoking more than 20 
cigarettes was very small and most subjects reported 
smoking 1–20 cigarettes, interactions were explored 
only for the 1–20 cigarettes category. Before excluding 
subjects with salivary cotinine >40 ng/mL per cigarette, 
statistically signifi cant interactions were seen between 
number of cigarettes and both waiting time after waking 
up until fi rst cigarette is smoked, and cigarette type. Not 
shown in the Table, the predicted increases in cotinine 
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concentration per cigarette smoked (ng/mL) were found 
to be for the former variable: within fi ve minutes, 1.5; 
more than fi ve minutes, 8.3 (p for interaction =0.02); 
and for the latter variable: “light”, 7.9; regular, 2.6 (p 
for interaction=0.009). However, after exclusion of 
subjects whose salivary cotinine concentrations were 
greater than 40 ng/mL per cigarette, no signifi cant inte-
ractions or important heterogeneities remained.
DISCUSSION
In the present and previous studies, the increase in co-
tinine per cigarette smoked in the past 24 (or, in some 
studies, 48) hours seems to be particularly evident up 
to an infl ection point of about 20 cigarettes. Over this 
amount the slope noticeably decreases, which would 
indicate that cotinine is a weak predictor of the number 
of cigarettes in those individuals who smoke more 
than one pack per day.10,11,17 This fi nding suggests that 
smokers satisfy their dependence-related craving with 
around 20 cigarettes per day. Also, corroborating pre-
vious studies,8,9,13 marked inter-individual variability 
was found in cotinine levels for the same number of 
cigarettes smoked (Figure).
A direct relationship of salivary cotinine was found 
with age, regardless of number of cigarettes, although 
it was not statistically signifi cant. Two previous studies 
have similarly found a weak association between age 
and cotinine levels.11,17 A weak or no association with 
age found in the present and previous studies suggests 
that cotinine metabolism does not seem to change as 
individuals’ age.13,19
Mean cotinine levels were found to be higher in men, 
although not signifi cantly at α=0.05. Prior research 
has been inconsistent with regard to the relationship 
between cotinine and gender. In a recent study by Etter 
et al,11 (2000) males were found to have higher mean 
concentration of salivary cotinine than women, regar-
dless of the number of cigarettes, duration of smoking, 
nicotine yield, FTND index score, attempts to stop 
smoking in the past year, perceived diffi culty to quit 
smoking, and stage of change with regard to intention 
to quit smoking. Benowitz et al2 recently reported that 
nicotine and cotinine are metabolized more rapidly in 
women than men. More rapid metabolism may explain, 
at least in part, the lower levels of cotinine seen in wo-
men compared to men in the present study. However, 
other studies have found that cotinine concentration per 
cigarette smoked was similar in men and women.4
The concentration of cotinine was higher in subjects 
with lower BMI, even after multiple adjustment. The 
concentration of cotinine in the body varies according 
to the daily intake of nicotine, the extent of conversion 
of nicotine to cotinine, and the rate of cotinine meta-
bolism.5 That salivary cotinine appears to increase in 
individuals who lose weight even while they continue 
smoking the same number of cigarettes suggests that 
either a great amount of nicotine is converted to coti-
nine or that the rate of cotinine metabolism is slower 
in individuals with lower BMI.16,21
In the present study, after controlling for the number of 
cigarettes smoked, the mean level of salivary cotinine 
was higher in subjects who reported smoking within 
fi ve minutes after waking up than in those who reported 
waiting for a longer period. This fi nding and the positive 
correlation between Fagerström Tolerance Questionnai-
re (FTQ) or FTND12 score and biochemical measures of 
nicotine intake – like saliva or blood cotinine or blood 
nicotine – seen in other studies14,23 indicate that higher 
levels of nicotine dependence can be associated with 
greater daily intake of nicotine, and therefore higher 
cotinine levels.
For the 1–20 cigarettes category, higher concentration 
of cotinine was seen in those who reported inhaling 
>1/2 time, with the adjusted difference found to be 
signifi cant – probably refl ecting increased absorption 
of nicotine – before excluding those with cot>40. Ho-
wever, no signifi cant associations were found between 
cotinine concentration and depth of inhaling. A possible 
misclassifi cation bias related to depth of inhaling may 
explain this apparently inconsistent result.
No signifi cant association was found between cotinine 
concentration and duration, although among those re-
porting 1–20 cigarettes in the past 24 hours, a pattern 
of higher mean levels of cotinine with longer duration 
of smoking (>25 years) was seen. In Etter et al11 stu-
dy (2000) they reported a positive association with 
duration, which, however, disappeared after multiple 
adjustment. 
The authors failed to fi nd differences in cotinine levels 
between those who reported smoking either “light” or 
regular yield cigarettes. Changes in cigarette design 
– such as ventilation holes in cigarette fi lters, more 
efficient filters, or more rapidly burning cigarette 
paper – are designed to decrease machine-determined 
measures of tar and nicotine. They result in changes 
in conscious or unconscious smoking behavior. These 
changes in smokers of “light” nicotine yield cigarettes 
include increased volume and frequency of puffs, and 
attempts at covering ventilation holes with fi nger or 
lips.20,* Benowitz & Jacob7 (1984) noted that low-yield 
cigarette smokers smoked 25% more cigarettes, and 
absorbed 60% more nicotine per cigarette than pre-
* National Institutes of Health. National Cancer Institute. Risks associated with smoking cigarettes with Low Machine-Measured Yields of Tar 
and Nicotine. Smoking and Tobacco Control. Rockville: National Institutes of Health; 2001. (Monograph, 13). Available from: http://cancer-
control.cancer.gov/tcrb/monographs/13/m13_complete.pdf
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dicted by the Federal Trade Commission. According 
to Benowitz et al8 (1983), only about 4% to 5% of the 
total serum cotinine variance can be explained by ni-
cotine yield. Results of previous studies are, therefore, 
consistent with the authors’ failure to fi nd a difference 
in cotinine concentration between smokers of “light” 
and smokers of regular cigarettes.
For the analysis of interactions, there were excluded 
subjects smoking more than 20 cigarettes, in whom the 
increase in mean cotinine with increasing number of 
cigarettes was found to be negligible. In those smoking 
1–20 cigarettes, two modifi ers of the effect of number 
of cigarettes on cotinine concentration were found. 
The fi rst one was a marker of addiction, which is the 
length of time individuals waits before smoking their 
fi rst cigarette; and the second modifi er was the type 
of cigarette (“light” vs. regular cigarette). Stronger 
associations were seen in those who waited more than 
fi ve minutes before smoking their fi rst cigarette and in 
those who reported smoking “light” cigarettes. These 
fi ndings, which are consistent with a study conducted in 
China,17 suggest that these individuals adopt an adaptive 
behavior, such as increasing the number of puffs or 
depth of inhaling, so as to reach a “satisfactory” level 
of nicotine while at the same time avoiding serious 
side effects. However, it is possible that the interac-
tions found resulted from measurement error as they 
disappeared with the exclusion of subjects with cotinine 
levels greater than 40 ng/mL per cigarette.
The present study’s limitations included its reliance 
on information provided by subjects with regard to 
the independent variables. Whenever possible, further 
studies should try to validate subject information with 
objective measures, such as determination of nicotine 
yield using smoking machines. The study’s strengths 
included its population-based design, high participation 
rate, and stringent quality control measures.
In conclusion, the present study was the fi rst to assess 
determinants of cotinine concentration in a Brazilian 
population. Of practical public health importance, the 
marked racial admixture in Brazil and the consistency 
between this study’s fi ndings and those reported in 
populations with different ethnic backgrounds suggest 
that predictors of cotinine levels, especially number of 
cigarettes, are similar across different populations. The 
results of the present study showed that self-reports of 
smoking fi ve minutes after waking up, and inhaling 
more than ½ the time are consistent with higher coti-
nine levels and therefore are likely accurate markers 
of dependence and higher nicotine intake. Accurate 
information on nicotine intake provided by salivary 
cotinine in the present study is useful for better asses-
sment of recent smoking not only in epidemiological 
studies but also as a therapeutic guide in smoking 
cessation programs.
miolo41_6.indb   961 14/11/2007   18:12:14
962 Determinants of salivary cotinine level     Figueiredo VC et al.
1. Ahijevych KL, Wewers ME. Patterns of cigarette 
consumption and cotinine levels among African 
American women smokers. Am J Respir Crit Care Med. 
1994;150(5 Pt 1):1229-33.
2. Benowitz NL, Swan GL, Lessov CN, Jacob P 3rd. 
Oral contraceptives induce CYP2A6 activity and 
accelerate nicotine metabolism. Clin Pharmacol Ther. 
2004;75(2):36.
3. Benowitz NL, Pérez-Stable EJ, Herrea B, Jacob P 3rd. 
Slower metabolism and reduced intake of nicotine 
from cigarette smoking in Chinese-Americans. J Natl 
Cancer Inst. 2002;94(2):108-15.
4. Benowitz NL, Hatsukami D. Gender differences in 
the pharmacology of nicotine addiction. Addict Biol. 
1998;3(4):383-404.
5. Benowitz NL. Cotinine as a biomarker of 
environmental tobacco exposure. Epidemiol Rev. 
1996;18(2):188-204.
6. Benowitz NL, Jacob P 3rd, Denaro C, Jenkins R. Stable 
isotope studies of nicotine kinetics and bioavailability. 
Clin Pharmacol Ther. 1991; 49(3):270-7.
7. Benowitz NL, Jacob P 3rd. Nicotine and carbon 
monoxide intake from high- and low-yield cigarettes. 
Clin Pharmacol Ther. 1984;36(2):265-70.
8. Benowitz NL, Hall SM, Herning RI, Jacob P 3rd, Jones 
RT, Osman AL. Smokers of low-yield cigarettes do not 
consume less nicotine. N Engl J Med.1983;309(3):139-
42.
9. Benowitz NL, Kuyt F, Jacob P 3rd. Circadian blood 
nicotine concentrations during cigarette smoking. Clin 
Pharmacol Ther.1982;32(6):758-64.
10. Caraballo RS, Giovino GA, Pechacek TF, Mowery 
PD, Richter PA, Strauss WJ, et al. Racial and ethnic 
differences in serum cotinine levels of cigarette smokers. 
Third National Health and Nutrition Examination 
Survey 1988-1991. JAMA. 1998;280(2):135-9.
11. Etter JF, Vu Duc T, Perneger TV. Saliva cotinine 
level in Smokers and nonsmokers. Am J Epidemiol. 
2000;151(3):251-8.
12. Fagerstrom KO. Measuring degree of physical 
dependency to tobacco smoking with reference to 
individualization of treatment. Addict Behav. 1978;3(3-
4):235 -41.
13. Gourlay SG, Benowitz NL, Forbes A, McNeil 
JJ. Determinants of plasma concentrations of 
nicotine and cotinine during cigarette smoking and 
transdermal nicotine treatment. Eur J Clin Pharmacol. 
1997;51(5):407-14.
14. Heartheton TF, Kozlowski LT, Frecker RC, Fagerström 
KO. The Fagerström Test for Nicotine Dependence: a 
revision of the Fagerström Tolerance Questionnaire. Br 
J Addict. 1991;86(9):1119-27.
15. Herning RI, Jones RT, Benowitz NL, Mines AH. How a 
cigarette is smoked determines nicotine blood levels. 
Clin Pharmacol Ther.1983;33(1):84-90.
16. Istvan JA, Nides MA, Buist AS, Greene P, Voelker H. 
Salivary cotinine, frequency of cigarette smoking, 
and body mass index: fi ndings at baseline in the Lung 
Health Study. Am J Epidemiol. 1994;139(6):628-36.
17. Jaakkola MS, Ma J, Yang G, Chin MF, Benowitz NL, 
Ceraso M, et al. Determinants of salivary cotinine 
concentrations in Chinese male smokers. Prev Med. 
2003;36(3):282-90.
18. Jacob P 3rd, Wilson M, Benowitz NL. Improved gas 
chromatography method for the determination of 
nicotine and cotinine in biologic fl uids. J Chromatogr. 
1981;222(1):61-70.
19. Molander L, Hansson A, Lunell E. Pharmacokinetics 
of nicotine in healthy elderly people. Clin Pharmacol 
Ther. 2001;69(1):57-65.
20. Nakayama T, Yokoyama T, Yoshiike N, Ichimura T, 
Yamamoto A, Tanaka H. Behavioral factors predicting 
serum cotinine concentrations of male smokers in a 
Japanese community. J Epidemiol. 1999;9(3):143-5.
21. Niaura R, Clark MM, Raciti MA, Pera V, Abrams DB. 
Increased saliva cotinine concentrations in smokers 
during rapid weight loss. J Consult Clin Psychol. 
1992;60(6):985-7.
22. Pérez Stable EJ, Herrera B, Jabob P 3rd, Benowitz NL. 
Nicotine metabolism and intake in black and white 
smokers. JAMA. 1998;280(2):152-6.
23. Prokhorov AV, Moor C, Pallonen UE, Hudmon KS, 
Koehly L, Hu S. Validation of the modifi ed Fagerström 
tolerance questionnaire with salivay cotinine among 
adolescents. Addict Behav. 2000;25(3):429-33.
REFERENCES 
Supported by the Fogarty International Center of the National Institutes of Health in the United States (grant number R01-
HL-73699); and Smith Klein Beecham Consumer Healthcare to Institute of Global Tobacco Control at the Bloomberg School 
of Public Health, Johns Hopkins University.
miolo41_6.indb   962 14/11/2007   18:12:14
